LifeSci Capital Reaffirms Buy Rating on Centessa Pharmaceuticals (CNTA) with a $39 PT, Anticipates Key Orexin Pipeline DataSeptember 15, 2025Yahoo Finance
LifeSci Capital Reaffirms Buy Rating on Centessa Pharmaceuticals (CNTA) with a $39 PT, Anticipates Key Orexin Pipeline DataSeptember 15, 2025Yahoo Finance
Chime Launches New Credit Card with Cash Back Rewards, Updated Design to Attract, Retain MembersSeptember 15, 2025Yahoo Finance
Chime Launches New Credit Card with Cash Back Rewards, Updated Design to Attract, Retain MembersSeptember 15, 2025Yahoo Finance
BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic DermatitisSeptember 15, 2025Yahoo Finance
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PTSeptember 15, 2025Yahoo Finance
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PTSeptember 15, 2025Yahoo Finance
Pantera-Backed Solana Treasury Firm Helius Raises $500M, Stock Soars Over 200%September 15, 2025Yahoo Finance
Pantera-Backed Solana Treasury Firm Helius Raises $500M, Stock Soars Over 200%September 15, 2025Yahoo Finance
Goldman, T. Rowe to sell alternative investments for wealthy by year end, retirement accounts next yearSeptember 15, 2025Yahoo Finance
Goldman, T. Rowe to sell alternative investments for wealthy by year end, retirement accounts next yearSeptember 15, 2025Yahoo Finance
